These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 10365731)

  • 21. Acute renal failure related to high-dose celecoxib.
    Graham MG
    Ann Intern Med; 2001 Jul; 135(1):69-70. PubMed ID: 11434756
    [No Abstract]   [Full Text] [Related]  

  • 22. Celecoxib for rheumatoid arthritis.
    Megeff CE; Strayer SM
    J Fam Pract; 2000 Feb; 49(2):108-9. PubMed ID: 10718683
    [No Abstract]   [Full Text] [Related]  

  • 23. [Selective Cox-2 inhibitor in osteoarthritis and rheumatoid arthritis. No increased risk for the heart].
    MMW Fortschr Med; 2003 Mar; 145(11):60. PubMed ID: 12688204
    [No Abstract]   [Full Text] [Related]  

  • 24. [Mobility and quality of life for arthrosis and rheumatism patients. Modern pain management with selective cox-2 inhibition].
    MMW Fortschr Med; 2002 Jul; 144(29-30):52. PubMed ID: 12219613
    [No Abstract]   [Full Text] [Related]  

  • 25. [COX-2 inhibitors: a new treatment in rheumatic diseases].
    Puddu G; Cravero E
    Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The cost effectiveness of rofecoxib and celecoxib in patients with osteoarthritis or rheumatoid arthritis.
    Maetzel A; Krahn M; Naglie G
    Arthritis Rheum; 2003 Jun; 49(3):283-92. PubMed ID: 12794781
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized controlled trial.
    Bensen WG; Fiechtner JJ; McMillen JI; Zhao WW; Yu SS; Woods EM; Hubbard RC; Isakson PC; Verburg KM; Geis GS
    Mayo Clin Proc; 1999 Nov; 74(11):1095-105. PubMed ID: 10560596
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Clinical pharmacology of the selective COX-2 inhibitors].
    Burian M; Geisslinger G
    Orthopade; 2003 Dec; 32(12):1078-87. PubMed ID: 14655004
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Upper gastrointestinal tolerability of celecoxib, a COX-2 specific inhibitor, compared to naproxen and placebo.
    Bensen WG; Zhao SZ; Burke TA; Zabinski RA; Makuch RW; Maurath CJ; Agrawal NM; Geis GS
    J Rheumatol; 2000 Aug; 27(8):1876-83. PubMed ID: 10955327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute onset of auditory hallucinations after initiation of celecoxib therapy.
    Lantz MS; Giambanco V
    Am J Psychiatry; 2000 Jun; 157(6):1022-3. PubMed ID: 10831492
    [No Abstract]   [Full Text] [Related]  

  • 31. Upper gastroduodenal ulceration in arthritis patients treated with celecoxib.
    Ashcroft DM; Chapman SR; Clark WK; Millson DS
    Ann Pharmacother; 2001; 35(7-8):829-34. PubMed ID: 11485128
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Celecoxib versus naproxen and diclofenac in osteoarthritis patients: SUCCESS-I Study.
    Singh G; Fort JG; Goldstein JL; Levy RA; Hanrahan PS; Bello AE; Andrade-Ortega L; Wallemark C; Agrawal NM; Eisen GM; Stenson WF; Triadafilopoulos G;
    Am J Med; 2006 Mar; 119(3):255-66. PubMed ID: 16490472
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Celecoxib].
    Fux R; Mörike K; Gleiter CH
    Dtsch Med Wochenschr; 2002 Apr; 127(15):803-4. PubMed ID: 11951138
    [No Abstract]   [Full Text] [Related]  

  • 34. Cardiorenal effects of celecoxib as compared with the nonsteroidal anti-inflammatory drugs diclofenac and ibuprofen.
    Whelton A; Lefkowith JL; West CR; Verburg KM
    Kidney Int; 2006 Oct; 70(8):1495-502. PubMed ID: 16941030
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [The efficacy of selective Cox-2-inhibitors in comparison with conventional NSAIDs].
    Krüger K
    MMW Fortschr Med; 2005 Aug; 147(31-32):28-30. PubMed ID: 16128193
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Celecoxib and the CLASS study--a statement].
    Wibe E; Maehlum S
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2218. PubMed ID: 12426902
    [No Abstract]   [Full Text] [Related]  

  • 37. Drug switching patterns among patients with rheumatoid arthritis and osteoarthritis using COX-2 specific inhibitors and non-specific NSAIDs.
    Zhao SZ; Wentworth C; Burke TA; Makuch RW
    Pharmacoepidemiol Drug Saf; 2004 May; 13(5):277-87. PubMed ID: 15133778
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [New treatment of pain and fever in rheumatoid arthritis and arthrosis. The first cyclooxygenase-2 inhibitors show promising results].
    Oliw E; Wollheim FA
    Lakartidningen; 2000 Jun; 97(24):2942-4. PubMed ID: 10900877
    [No Abstract]   [Full Text] [Related]  

  • 39. [Celecoxib and the CLASS study--worse and worse...].
    Slørdal L
    Tidsskr Nor Laegeforen; 2002 Sep; 122(22):2219. PubMed ID: 12426903
    [No Abstract]   [Full Text] [Related]  

  • 40. Update on clinical developments with celecoxib, a new specific COX-2 inhibitor: what can we expect?
    Geis GS
    Scand J Rheumatol Suppl; 1999; 109():31-7. PubMed ID: 10422544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.